breast cancer breast carcinoma
Conditions
Interventions
Wire Guided Localisation technique
Patients in the WGL group will undergo intratumoural injection of a nuclear
radiotracer under stereotactic or ultrasound guidance, after injection a
scintigraphic
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients with a non palpable breast carcinoma who are eligible for a lumpectomy and sentinel node biopsy
Exclusion criteria
Exclusion criteria: - Pregnant or lactating patients - Patients with a multi focal carcinoma - Patients with ductal carcinoma in situ (DCIS) or a lobular carcinoma in situ (LCIS) without invasive growth
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) The percentage of tumour-free margins (invasive and in situ) after the ROLL vs. the WGL procedure (i.e. oncologic outcome). 2) The volume and maximum diameter of the lumpectomy of ROLL vs. WGL (i.e. cosmetic outcome). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) The cost-effectiveness of ROLL vs. WGL (i.e. operation time, radiological localisation time, hospital stay and materials). 2) The degree of difficulty of the radiological and surgical procedure. 3) The degree of patient (dis)comfort of the radiological procedure ROLL vs. WGL (number of procedures, pain, complications). 4) The success rate of the sentinel node procedure (visualisation and localisation). | — |
Countries
Netherlands
Outcome results
None listed